Borosil Scientific Q1 FY27: Revenue ₹106.8 Cr, PAT ₹4.4 Cr
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹100Cr
- +12.2% YoY
- −24.3% QoQ
- Net profit
- ₹7Cr
- +1387% YoY
- −68.2% QoQ
- Margin
- 11.07%
- +1.1 pp YoY
- −12.5 pp QoQ
Top 10 Industrial Products companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Borosil Scientific Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr) - Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr) - EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: Q1FY27 Consolidated EBITDA: ₹8.7 crores, up 50.1% YoY - Q1FY27 Consolidated EBITDA Margin: 8.2% - Q1FY27 Consolidated PAT: ₹4.4 crores, up 203.5% YoY - Q1FY27 Standalone EBITDA: ₹11.5 crores, up 15.3% YoY - Q1FY27 Standalone EBITDA Margin: 11.5% - Q1FY27 Standalone PAT: ₹6.8 crores, up 1396% YoY - Explicit Margin Outlook: Medium-term goal to improve EBITDA margins through emphasis on high-margin Process Sciences and lab equipment, maintaining an annual pricing strategy, vigilant expense control, and focus on renewable energy (Page 18-19).
From Borosil Scientific Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr)
- Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr)
- EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: ₹5.8 Cr)
- EBITDA (Standalone): ₹11.5 Cr, up 15.3% YoY (Q1FY26: ₹9.9 Cr)
- Category-wise Q1FY27 sales growth YoY:
- Lab Consumables: ₹45.8 Cr, flat (-0.1%)
- Lab Equipment: ₹12.3 Cr, +31.4%
- Process System: ₹8.5 Cr, +8.6%
- Pharma Packaging: ₹23.1 Cr, +31.6%
- Domestic Glassware: ₹15.3 Cr, +4.0%
- Others: ₹1.7 Cr, +175.6%
2 more points from Borosil Scientific Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Borosil Scientific Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points from Borosil Scientific Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Borosil Scientific Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Borosil Scientific Ltd said on order book & pipeline — free account, 30 seconds.
Borosil Scientific Ltd — Quarterly revenue & net profit
Borosil Scientific Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 100 | 89 | +12.2% | 132 | -24.3% |
| Operating profit (EBITDA) | 11 | 9 | +24.8% | 31 | -64.4% |
| Operating margin | 11.07% | 9.95% | +1.1 pp | 23.57% | -12.5 pp |
| Profit before tax | 9 | 1 | +1310.6% | 29 | -67.7% |
| Net profit (PAT) | 7 | 0 | +1387% | 22 | -68.2% |
| EPS (₹) | 0.77 | 0.05 | +1440% | 2.42 | -68.2% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹104 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Borosil Scientific's management said in earlier quarters
Others in Industrial Products this season
- Expo Engineering (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹13.75 crore, down from ₹17.85 crore in Q1 FY26 (approx. Key investor presentation takeaways from Expo Engineering and Projects
- Shri Bajrang Alliance (Q1 FY27)
Shareholding pattern as of 30 June 2026: Promoter 63.97%, Public 36.03%. Key investor presentation takeaways from Shri Bajrang Alliance Ltd's Q1 FY27 investor p
- Bedmutha Industries (Q1 FY27)
Revenue from Operations for the year ended March 31, 2026: Rs 1466.74 crores versus Rs 1049.33 crores for March 31, 2025, indicating a significant year-on-year…
- Horizon Reclaim (Q1 FY27)
Reported Revenue (₹ Cr): . Key investor presentation takeaways from Horizon Reclaim (India) Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Borosil Scientific Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Borosil Scientific Ltd Q1 FY27 results?
Q1FY27 Consolidated net sales: ₹106.8 Cr, up 11.2% YoY (Q1FY26: ₹96.0 Cr) - Standalone net sales: ₹99.9 Cr, up 12.2% YoY (Q1FY26: ₹89.0 Cr) - EBITDA (Consolidated): ₹8.7 Cr, up 50.1% YoY (Q1FY26: Q1FY27 Consolidated EBITDA: ₹8.7 crores, up 50.1% YoY - Q1FY27 Consolidated EBITDA Margin: 8.2% - Q1FY27 Consolidated PAT: ₹4.4 crores, up 203.5% YoY - Q1FY27 Standalone EBITDA: ₹11.5 crores, up 15.3% YoY - Q1FY27 Standalone EBITDA Margin: 11.5% - Q1FY27 Standalone PAT: ₹6.8 crores, up 1396% YoY - Explicit Margin Outlook: Medium-term goal to improve EBITDA margins through emphasis on high-margin Process Sciences and lab equipment, maintaining an annual pricing strategy, vigilant expense control, and focus on renewable energy (Page 18-19).
What is Borosil Scientific Ltd share price analysis?
Borosil Scientific Ltd currently shows a neutral. The stock trades at a P/E of 23.9 with a market cap of ₹1,064 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Borosil Scientific Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
